Changing the way the world experiences healthcare requires that we all do more, in new ways, with new partners. Let’s do it together. At Medtronic, we will continue our leadership in CVI treatment through our commitment to deliver:
- Demonstrated Results – Medtronic CVI solutions offer clinically demonstrated results1-10. Our technologies are designed to provide improved patient comfort with:1,2,9
- Minimal pain and tenderness
- Reduced ecchymosis
- Rapid Recovery – Faster recovery can also mean increased patient satisfaction. Medtronic CVI solutions are designed to provide:
- Fast improvement in quality of life1,2
- Quick return to normal activities3,6
- Easy post-procedure management3
- Unparalleled Partnership – Medtronic is committed to being the best possible partner for your CVI practice. To support your practice and ensure the successful integration of endovascular CVI treatment technologies, we offer:
- Full access to a wide range of training programs focused on CVI care and treatment
- Dedicated, field-based support teams
Meaningful innovations. Better patient outcomes. Quality, coordinated care. Let’s take healthcare Further, Together.
1. Morrison, N. Use of Cyanoacrylate adhesive for Treatment of Incompetent Great Saphenous Veins: 12-month Results of the VeClose Trial, European Venous Forum, 2015.
2. Almeida JI, Kaufman J, Goekeritz O, et al. Radiofrequency Endovenous ClosureFAST versus Laser Ablation for the Treatment of Great Saphenous Reflux: A Multicenter, Single-Blinded, Randomized Study (Recovery Study). JVIR June 2009.
3. Proebstle TM, Alm J, Dimitri S et al. The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins. J Vasc Surg Venous and Lymphat Disord.
4. Proebstle, T. ClosureFast Long-Term European Multi-Center Study in Patients with Chronic Venous Insufficiency. American College of Phlebology 26th Annual Congress, 2012.
5. Almeida JI, Javier JJ, Mackay EG, Bautista C, Proebstle TM. First human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous and Lymphat Disord. 2013;1(2):174-80.
6. Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM. Two-year follow-up of first human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. Phlebology / Venous Forum of the Royal Society of Medicine, 2014.
7. Proebstle T, Alm J, Gockeritz O, et al. Three year European follow-up endovenous radiofrequency thermal ablation of the great saphenous vein with or without treatment of calf varicosities. J Vasc Surg. 2011;54(1)146-52.
8. L.H. Rasmussen, M. Lawaetz, L. Bjoern, B. Vennits, A. Blemings and B. Eklof, Randomized Clinical Trial Comparing Endovenous Laser Ablation, Radiofrequency Ablation, Foam Sclerotherapy and Surgical Stripping for Great Saphenous Varicose Veins. British Journal of Surgery Society Ltd., Wiley Online Library, www.bjs.co.uk, March 15, 2011.
9. Morrison N, Gibson K, McEnroe S, Goldman M, King t, Weiss R, Cher D, Jones A. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). Journal of Vascular Surgery.
10. National Institute for Health and Care Excellence 2013. Varicose veins in the legs: The diagnosis and management of varicose veins. Clinical guideline: Methods, evidence and recommendations July 2013, pg 36.